Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of V-01-351/V-01D Bivalent Vaccine Booster in Adults
NCT05273528Phase 2Unknown
- Sponsor
- Livzon Pharmaceutical Group Inc.
- Start
- Jan 2022
- Primary completion
- Jan 2023
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of V-01-351 + V-01D in coronavirus disease 2019 (COVID-19), sponsored by Livzon Pharmaceutical Group Inc.. Status: unknown.
02
Drugs
V-01-351 + V-01D
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05273528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05273528.